The association of Neoehrlichia mikurensis infection with polymyalgia rheumatica
Clinical Scorecard: The Link Between Neoehrlichia mikurensis Infection and Polymyalgia Rheumatica
At a Glance
Category Detail
Condition Neoehrlichiosis and Polymyalgia Rheumatica Key Mechanisms Intracellular infection of vascular endothelial cells by Neoehrlichia mikurensis, potentially triggering PMR-like symptoms. Target Population Older adults, particularly those aged 50 and above. Care Setting Primary care clinics in the Västra Götaland Region of Sweden.
Key Highlights
Neoehrlichia mikurensis is transmitted via tick bites and primarily affects older adults. Diagnosis of N. mikurensis requires PCR testing as it does not grow in culture. Patients with N. mikurensis infection may present with PMR-like symptoms. Polymyalgia rheumatica primarily affects individuals over 50, with a higher incidence in women. Corticosteroids are the mainstay of PMR treatment, with no specific autoantibodies identified. Guideline-Based Recommendations
Diagnosis
PCR testing of blood samples is necessary for diagnosing N. mikurensis. Management
Patients testing positive for N. mikurensis should receive oral doxycycline 100 mg twice daily for 3 weeks. Monitoring & Follow-up
Follow-up PCR testing for N. mikurensis is recommended after treatment. Risks
Immunocompromised patients may experience severe symptoms including fever, chills, and vascular events. Patient & Prescribing Data
Patients with active Polymyalgia Rheumatica.
Corticosteroids are the primary treatment for PMR; N. mikurensis infection may complicate the clinical picture.
Clinical Best Practices
Consider N. mikurensis infection in PMR patients presenting with atypical symptoms. Utilize PCR for accurate diagnosis of N. mikurensis. Related Resources & Content
